Brief: ARCA Biopharma Announces Q2 2022 Financial Results

Oruka Therapeutics

02/08/2022 22:32

Aug 2 (Reuters) - ARCA Biopharma Inc  ABIO.O :
    * ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2022 FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $0.22
    * ARCA BIOPHARMA - BELIEVES ITS CURRENT CASH AND CASH
EQUIVALENTS,
WILL BE SUFFICIENT TO FUND OPERATIONS AT CURRENT LEVELS THROUGH
AT LEAST END OF 2023
    * CASH AND CASH EQUIVALENTS WERE $46.4 MILLION AS OF JUNE
30,
2022, COMPARED TO $53.4 MILLION AS OF DECEMBER 31, 2021

Source text for Eikon:  ID:nGNX6Lzdd2 
Further company coverage:  ABIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))